M3

Latch Adds M3 Retrofit Lock to its Lineup of Smart Locks

Retrieved on: 
星期一, 四月 29, 2024

Latch, Inc. , soon to be Door.com , today announced its new M3 Retrofit Lock, which is designed to retrofit common mortise locks from Schlage, Sargent, Corbin, Marks, and Best.

Key Points: 
  • Latch, Inc. , soon to be Door.com , today announced its new M3 Retrofit Lock, which is designed to retrofit common mortise locks from Schlage, Sargent, Corbin, Marks, and Best.
  • The new M3 joins Latch’s suite of locks, access control solutions, and building monitoring systems that help Latch customers deliver value to their residents and generate more NOI.
  • “The team at Latch is laser focused on delivering affordable and easy-to-use products and services, like the new M3 Retrofit Lock, that generate NOI for our customers and make residents’ lives easier,” said Jamie Siminoff, Chief Doorman.
  • The M3 Retrofit Lock is now available for pre-order and is expected to begin shipping later this year.

Edwards Lifesciences Reports First Quarter Results

Retrieved on: 
星期四, 四月 25, 2024

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2024.

Key Points: 
  • Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2024.
  • Surgical Structural Heart sales for the quarter were $266 million, which grew 7%, or 8% on a constant currency basis.
  • For the quarter, the adjusted gross profit margin was 76.0%, compared to 77.5% in the same period last year.
  • For the second quarter of 2024, the company projects total sales to be between $1.62 and $1.70 billion, and adjusted EPS of $0.67 to $0.71.

Economic Bulletin Issue 3, 2024

Retrieved on: 
星期四, 四月 25, 2024

The European Banking Authority (EBA) today launched a public consultation on its draft Regulatory Technical Standards (RTS) on the method for identifying the main risk driver and determining whether a transaction represents a long or a short position. These RTS are part of the Phase 1 deliverables of the EBA roadmap on the implementation of the EU banking package in the area of market risk. The consultation runs until 24 July 2024.

Key Points: 


The European Banking Authority (EBA) today launched a public consultation on its draft Regulatory Technical Standards (RTS) on the method for identifying the main risk driver and determining whether a transaction represents a long or a short position. These RTS are part of the Phase 1 deliverables of the EBA roadmap on the implementation of the EU banking package in the area of market risk. The consultation runs until 24 July 2024.

Apple Jing’an to welcome its first customers this Thursday, March 21, in Shanghai

Retrieved on: 
星期一, 三月 18, 2024

Apple® today previewed Apple Jing’an, located near Jing’an Temple and Jing’an Park in Shanghai.

Key Points: 
  • Apple® today previewed Apple Jing’an, located near Jing’an Temple and Jing’an Park in Shanghai.
  • “We’re thrilled to open Apple Jing’an — a store that seamlessly blends the traditional with the modern and perfectly complements this historic neighborhood in Shanghai,” said Deirdre O’Brien, Apple’s senior vice president of Retail.
  • From the design of the store to the materials used to bring it to life, every element of Apple Jing’an is built with purpose.
  • Opening festivities include a special performance by the youngest members of the Shanghai Symphony Orchestra to share the future of classical music in-store for customers.

Yiren Digital Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Retrieved on: 
星期四, 三月 21, 2024

BEIJING, March 21, 2024 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China, today announced its unaudited financial results for the quarter ended December 31, 2023.

Key Points: 
  • BEIJING, March 21, 2024 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China, today announced its unaudited financial results for the quarter ended December 31, 2023.
  • For the fiscal year of 2023, total gross written premiums were RMB4,893.0 million, compared to RMB3,936.6 million in 2022.
  • For the fiscal year of 2023, total gross merchandise volume was RMB1,960.3 million, compared to RMB687.8 million in 2022.
  • Total net revenue in the fourth quarter of 2023 was RMB1,274.3 million (US$179.5 million), representing an increase of 17.1% from RMB1,088.1 million in the fourth quarter of 2022.

RoboSense Wins 2024 Tech.AD Award for Perception and Sensing

Retrieved on: 
星期一, 三月 25, 2024

STUTTGART, Germany, March 12, 2024 /PRNewswire/ -- RoboSense (2498.HK), a global leader in lidar and perception solutions, today announced that its long-range, automotive-grade M3 lidar sensor won the Tech.AD Europe Award 2024, which recognizes outstanding achievements in the automotive industry. RoboSense's M3 was honored in the Perception and Sensing category for its lidar innovation that is powering the future of intelligent vehicles.

Key Points: 
  • STUTTGART, Germany, March 12, 2024 /PRNewswire/ -- RoboSense (2498.HK), a global leader in lidar and perception solutions, today announced that its long-range, automotive-grade M3 lidar sensor won the Tech.AD Europe Award 2024 , which recognizes outstanding achievements in the automotive industry.
  • RoboSense's M3 was honored in the Perception and Sensing category for its lidar innovation that is powering the future of intelligent vehicles.
  • The 2024 Tech.AD Europe award provides further validation that, with the M3, we are delivering on that promise, said Mingzhe Sun, Operations Director, RoboSense EMEA GmbH.
  • Representing RoboSense EMEA GmbH at Tech.AD and accepting this prestigious award are Gregory Poillion, Senior Sales Director , Felix Yang, Sales Director , and Mingzhe Sun, Operations Director.

Cango Inc. Reports Fourth Quarter and Full Year 2023 Unaudited Financial Results

Retrieved on: 
星期一, 三月 11, 2024

SHANGHAI, March 11, 2024 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a leading automotive transaction service platform in China, today announced its unaudited financial results for the fourth quarter and full year of 2023.

Key Points: 
  • SHANGHAI, March 11, 2024 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a leading automotive transaction service platform in China, today announced its unaudited financial results for the fourth quarter and full year of 2023.
  • "With keen insight into market conditions and industry trends, Cango strategically consolidated its two platforms, 'Cango Haoche' for new cars and 'Cango U-car' for used cars, into a single integrated 'Cango U-car' APP in 2023.
  • Mr. Yongyi Zhang, Chief Financial Officer of Cango, stated, "China's uneven economic recovery impacted our business throughout 2023.
  • Net recovery on provision for credit losses in the fourth quarter of 2023 was RMB31.2 million (US$4.4 million).

Carbon Unveils Dental Lab Automation Tools with the Launch of its Revolutionary Automatic Operation Suite at Lab Day Chicago 2024

Retrieved on: 
星期五, 二月 23, 2024

REDWOOD CITY, Calif., Feb. 23, 2024 /PRNewswire/ -- Today at Lab Day Chicago, Carbon, a leading product development and manufacturing technology company, announced its Automatic Operation (AO) suite of solutions designed to transform the landscape of dental lab automation. The innovative suite of automation solutions is designed to specifically meet the needs of dental labs, setting a new standard in lab automation and efficiency. By integrating the AO suite into workflows, labs not only benefit from Carbon's unmatched efficiency and precision but also greatly reduce print turnover times and processing labor.

Key Points: 
  • The innovative suite of automation solutions is designed to specifically meet the needs of dental labs, setting a new standard in lab automation and efficiency.
  • "The launch of our Automatic Operation suite marks a pivotal step on our journey to elevate the dental lab industry," said Phil DeSimone, CEO and Co-Founder.
  • Carbon's AO suite is a leap forward in advanced dental lab technology, emphasizing efficiency, reliability, and scalability.
  • For more information about Carbon's Automatic Operation Suite and its components, visit www.carbon3d.com or contact your local Carbon representative.

Maxon Release Offers Apple M3 Optimization, Streamlined Workflows and More

Retrieved on: 
星期三, 二月 21, 2024

BAD HOMBURG, Germany, Feb. 21, 2024 /PRNewswire-PRWeb/ -- Maxon, developers of professional software solutions for editors, filmmakers, motion designers, visual effects artists, and creators of all types, today announced updates to several products included in the Maxon One subscription.

Key Points: 
  • This month's release brings substantial performance enhancements for systems running on Apple's M3 family of chips by leveraging Apple's support for hardware-accelerated ray tracing in Redshift.
  • Artists will benefit from outstanding performance thanks to the next generation GPU of the M3 family of chips, resulting in lightning-fast renders and better interactivity.
  • This release includes support for the next-generation GPU that represents the biggest leap forward in graphics architecture ever for Apple silicon.
  • This release offers artists improved connections with essential tools that streamline workflows and enhance file format compatibility to simplify access to your digital assets.

Edwards Lifesciences Reports Fourth Quarter Results

Retrieved on: 
星期二, 二月 6, 2024

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended December 31, 2023.

Key Points: 
  • Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended December 31, 2023.
  • In the fourth quarter, Edwards remained focused on its key value drivers to unlock the significant long-term opportunity for patients: a portfolio of differentiated therapies; positive clinical trial results to support approvals and adoption; and favorable real-world clinical outcomes.
  • Research and development expenses in the fourth quarter grew 16 percent over the prior year to $270 million, or 17.6 percent of sales.
  • During the fourth quarter, the company repurchased $444 million of stock through a combination of a pre-established trading plan and accelerated share repurchase programs.